Division of Nephrology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
School of Medicine, South China University of Technology, Guangzhou, China.
Am J Physiol Renal Physiol. 2021 Mar 1;320(3):F262-F272. doi: 10.1152/ajprenal.00289.2020. Epub 2020 Dec 28.
Mitochondrial damage in renal tubular epithelial cells (RTECs) is a hallmark of endotoxin-induced acute kidney injury (AKI). Forkhead box O1 (FOXO1) is responsible for regulating mitochondrial function and is involved in several kidney diseases. Here, we investigated the effect of FOXO1 on endotoxin-induced AKI and the related mechanism. In vivo, FOXO1 downregulation in mouse RTECs and mitochondrial damage were found in endotoxin-induced AKI. Overexpression of FOXO1 by kidney focal adeno-associated virus (AAV) delivery improved renal function and reduced mitochondrial damage. Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1-α), a master regulator of mitochondrial biogenesis and function, was reduced in endotoxin-induced AKI, but the reduction was reversed by FOXO1 overexpression. In vitro, exposure to LPS led to a decline in HK-2 cell viability, mitochondrial fragmentation, and mitochondrial superoxide accumulation, as well as downregulation of FOXO1, PGC1-α, and mitochondrial complex I/V. Moreover, overexpression of FOXO1 in HK-2 cells increased HK-2 cell viability and PGC1-α expression, and it alleviated the mitochondrial injury and superoxide accumulation induced by LPS. Meanwhile, inhibition of FOXO1 in HK-2 cells by siRNA treatment decreased PGC1-α expression and HK-2 cell viability. Chromatin immunoprecipitation assays and PCR analysis confirmed that FOXO1 bound to the promoter in HK-2 cells. In conclusion, downregulation of FOXO1 in RTECs mediated endotoxin-induced AKI and mitochondrial damage. Overexpression of FOXO1 could improve renal injury and mitochondrial dysfunction, and this effect occurred at least in part as a result of PGC1-α signaling. FOXO1 might be a potential target for the prevention and treatment of endotoxin-induced AKI.
线粒体损伤是内毒素诱导急性肾损伤(AKI)的标志。叉头框蛋白 O1(FOXO1)负责调节线粒体功能,并参与多种肾脏疾病。本研究旨在探讨 FOXO1 在内毒素诱导的 AKI 中的作用及其相关机制。在体内,内毒素诱导的 AKI 中发现小鼠肾小管上皮细胞(RTEC)中的 FOXO1 下调和线粒体损伤。肾脏局灶腺相关病毒(AAV)转染过表达 FOXO1 可改善肾功能并减少线粒体损伤。过氧化物酶体增殖物激活受体-γ共激活因子 1-α(PGC1-α)是线粒体生物发生和功能的主要调节因子,在内毒素诱导的 AKI 中减少,但过表达 FOXO1 可逆转其减少。在体外,LPS 暴露导致 HK-2 细胞活力下降、线粒体碎片化和线粒体超氧化物积累减少,以及 FOXO1、PGC1-α和线粒体复合物 I/V 的下调。此外,HK-2 细胞中 FOXO1 的过表达增加了 HK-2 细胞活力和 PGC1-α的表达,并减轻了 LPS 诱导的线粒体损伤和超氧化物积累。同时,siRNA 处理抑制 HK-2 细胞中的 FOXO1 降低了 PGC1-α的表达和 HK-2 细胞活力。染色质免疫沉淀分析和 PCR 分析证实,FOXO1 与 HK-2 细胞中的启动子结合。总之,RTEC 中 FOXO1 的下调介导了内毒素诱导的 AKI 和线粒体损伤。过表达 FOXO1 可以改善肾脏损伤和线粒体功能障碍,这种作用至少部分是通过 PGC1-α 信号发生的。FOXO1 可能是预防和治疗内毒素诱导的 AKI 的潜在靶点。